Personal information

Other IDs

Loop profile: 2168618

Activities

Collapse all

Employment (2)

Institut d'Investigacio Biomedica de Bellvitge: Barcelona, ES

Employment
Source: Self-asserted source
Pau Cerdà

Hospital Universitari de Bellvitge: L'Hospitalet de Llobregat, Catalunya, ES

(Internal Medicine)
Employment
Source: Self-asserted source
Pau Cerdà

Education and qualifications (3)

Bellvitge University Hospital: Barcelona, ES

2013 to 2018 | Medical Speciality Training Program (Internal Medicine)
Education
Source: Self-asserted source
Pau Cerdà

Universitat Autònoma de Barcelona: Barcelona, ES

2015 to 2017 | Biostatistics in health science
Education
Source: Self-asserted source
Pau Cerdà

Universitat Autònoma de Barcelona: Barcelona, ES

2006 to 2012 | Medicine
Education
Source: Self-asserted source
Pau Cerdà

Professional activities (2)

Sociedad Española de Medicina Interna: Madrid, ES

Membership
Source: Self-asserted source
Pau Cerdà

Sociedad Catalana y Balear de Medicina Interna: Barcelona, ES

Membership
Source: Self-asserted source
Pau Cerdà

Funding (2)

P-FIS

2022 to 2025 | Grant
Instituto de Salud Carlos III (Madrid, ES)
GRANT_NUMBER:

FI21/00007
Source: Self-asserted source
Pau Cerdà

FIS

2021 to 2023 | Grant
Instituto de Salud Carlos III (Madrid, ES)
GRANT_NUMBER:

PI20/00592
Source: Self-asserted source
Pau Cerdà

Works (22)

Pioneering the future: CRISPR-Cas9 gene therapy for hereditary hemorrhagic telangiectasia. Author's reply

European Journal of Internal Medicine
2024-09 | Journal article
DOI: 10.1016/j.ejim.2024.07.003
Contributors: Pau Cerdà; Cinthia Aguilera; Antoni Riera-Mestre
Source: check_circle
Crossref

Induced Endothelial Cell Cycle Arrest Prevents Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia

Circulation
2024-03-19 | Journal article
DOI: 10.1161/CIRCULATIONAHA.122.062952
Contributors: Gael Genet; Nafiisha Genet; Umadevi Paila; Shelby R. Cain; Aleksandra Cwiek; Nicholas W. Chavkin; Vlad Serbulea; Agnès Figueras; Pau Cerdà; Stephanie P. McDonnell et al.
Source: check_circle
Crossref

New genetic drivers in hemorrhagic hereditary telangiectasia

European Journal of Internal Medicine
2024-01 | Journal article
DOI: 10.1016/j.ejim.2023.08.024
Contributors: Pau Cerdà; Sandra D. Castillo; Cinthia Aguilera; Adriana Iriarte; José Luis Rocamora; Ane M. Larrinaga; Francesc Viñals; Mariona Graupera; Antoni Riera-Mestre
Source: check_circle
Crossref

Aflibercept for Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia: A Case Report

Medicina
2023-08-24 | Journal article
DOI: 10.3390/medicina59091533
Contributors: Bernat Villanueva; Adriana Iriarte; Raquel Torres-Iglesias; Miriam Muñoz Bolaño; Pau Cerdà; Antoni Riera-Mestre
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Hereditary hemorrhagic telangiectasia relapse in liver allograft

Medicina Clínica
2023-07 | Journal article
DOI: 10.1016/j.medcli.2023.06.021
Part of ISSN: 0025-7753
Contributors: Antoni Riera-Mestre; Pau Cerdà; Laura Lladó
Source: Self-asserted source
Pau Cerdà

Potential angiogenic biomarkers in hereditary hemorrhagic telangiectasia and other vascular diseases

European Journal of Internal Medicine
2023-05 | Journal article
DOI: 10.1016/j.ejim.2023.05.020
Part of ISSN: 0953-6205
Contributors: B. Villanueva; P. Cerdà; R. Torres-Iglesias; J.L. Rocamora; A. Figueras; F. Viñals; Nuria Aragay Vicente
Source: Self-asserted source
Pau Cerdà

Long-term use of somatostatin analogs for chronic gastrointestinal bleeding in hereditary hemorrhagic telangiectasia

Frontiers in Medicine
2023-05-12 | Journal article
DOI: 10.3389/fmed.2023.1146080
Part of ISSN: 2296-858X
Contributors: Raquel Torres-Iglesias; José María Mora-Luján; Adriana Iriarte; Pau Cerdà; Esther Alba; Miguel Ángel Sánchez-Corral; Ana Berrozpe; Francesc Cruellas; Enric Gamundí; Jesús Ribas et al.
Source: Self-asserted source
Pau Cerdà

Improving Hereditary Hemorrhagic Telangiectasia Molecular Diagnosis: A Referral Center Experience

Genes
2023-03-22 | Journal article
DOI: 10.3390/genes14030772
Contributors: Cinthia Aguilera; Ariadna Padró-Miquel; Anna Esteve-Garcia; Pau Cerdà; Raquel Torres-Iglesias; Núria Llecha; Antoni Riera-Mestre
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Perioperative Complications and Long-Term Follow-Up of Liver Transplantation in Hemorrhagic Hereditary Telangiectasia: Report of Three Cases and Systematic Review

Journal of Clinical Medicine
2022-09-24 | Journal article
DOI: 10.3390/jcm11195624
Contributors: Antoni Riera-Mestre; Pau Cerdà; Yoelimar Carolina Guzmán; Adriana Iriarte; Alba Torroella; José María Mora-Luján; Jose Castellote; Amelia Hessheimer; Constantino Fondevila; Laura Lladó
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Translational medicine in hereditary hemorrhagic telangiectasia

European Journal of Internal Medicine
2022-01 | Journal article
DOI: 10.1016/j.ejim.2021.09.003
Part of ISSN: 0953-6205
Contributors: Pau Cerdà
Source: Self-asserted source
Pau Cerdà

Catheter-Directed Therapies in Patients with Pulmonary Embolism: Predictive Factors of In-Hospital Mortality and Long-Term Follow-Up

Journal of Clinical Medicine
2021-10-14 | Journal article
DOI: 10.3390/jcm10204716
Contributors: Jesús Ribas; Joana Valcárcel; Esther Alba; Yolanda Ruíz; Daniel Cuartero; Adriana Iriarte; José María Mora-Luján; Marta Huguet; Pau Cerdà; Sergio Martínez-Yélamos et al.
Source: check_circle
Crossref

Adrenomedullin as a potential biomarker involved in patients with hereditary hemorrhagic telangiectasia

European Journal of Internal Medicine
2021-06 | Journal article
DOI: 10.1016/j.ejim.2021.03.039
Contributors: A. Iriarte; L. Ochoa-Callejero; J. García-Sanmartín; P. Cerdà; P. Garrido; J. Narro-Íñiguez; JM. Mora-Luján; A. Jucglà; MA Sánchez-Corral; F. Cruellas et al.
Source: check_circle
Crossref

Blood test dynamics in hospitalized COVID-19 patients: Potential utility of D-dimer for pulmonary embolism diagnosis.

PloS one
2020-12-28 | Journal article
DOI: 10.1371/journal.pone.0243533
PMID: 33370304
PMC: PMC7769556
Source: Self-asserted source
Pau Cerdà

Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2020-10-06 | Journal article
DOI: 10.1016/j.ijid.2020.09.1486
PMID: 33035673
PMC: PMC7537652
Source: Self-asserted source
Pau Cerdà

Direct oral anticoagulants versus vitamin K antagonists in antiphospholipid syndrome: A meta-analysis.

European journal of internal medicine
2020-05-29 | Journal article
DOI: 10.1016/j.ejim.2020.05.012
PMID: 32482595
Source: Self-asserted source
Pau Cerdà

Gender differences in hereditary hemorrhagic telangiectasia severity.

Orphanet journal of rare diseases
2020-03-02 | Journal article
DOI: 10.1186/s13023-020-1337-5
PMID: 32122373
PMC: PMC7053104
Source: Self-asserted source
Pau Cerdà

Gastrointestinal Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia: Risk Factors and Endoscopic Findings.

Journal of clinical medicine
2019-12-28 | Journal article
DOI: 10.3390/jcm9010082
PMID: 31905627
PMC: PMC7019907
Source: Self-asserted source
Pau Cerdà

PI3K (Phosphatidylinositol 3-Kinase) Activation and Endothelial Cell Proliferation in Patients with Hemorrhagic Hereditary Telangiectasia Type 1.

Cells
2019-08-24 | Journal article
DOI: 10.3390/cells8090971
PMID: 31450639
PMC: PMC6770684
Source: Self-asserted source
Pau Cerdà

Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry.

Orphanet journal of rare diseases
2019-08-09 | Journal article
DOI: 10.1186/s13023-019-1172-8
PMID: 31399146
PMC: PMC6688272
Source: Self-asserted source
Pau Cerdà

Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta-analysis.

Journal of thrombosis and haemostasis : JTH
2019-06-04 | Journal article
DOI: 10.1111/jth.14477
PMID: 31063646
Source: Self-asserted source
Pau Cerdà

Prognostic Role of Hyperuricemia in Acute Heart Failure.

Revista espanola de cardiologia (English ed.)
2016-05-18 | Journal article
DOI: 10.1016/j.rec.2016.03.014
PMID: 27209408
Source: Self-asserted source
Pau Cerdà

Mortality in type 2 diabetes patients admitted because of acute heart failure.

Revista clinica espanola
2016-04-14 | Journal article
DOI: 10.1016/j.rce.2016.03.003
PMID: 27086478
Source: Self-asserted source
Pau Cerdà

Peer review (2 reviews for 1 publication/grant)

Review activity for Orphanet journal of rare diseases. (2)
How many people are using ORCID?